IL‐1beta and Caspase‐1 Are Secreted Via Different Pathways

Jishu Shi,Shelly Aono,Liqiong Lan,Edward E. Morrison,Wuyuan Lu
DOI: https://doi.org/10.1096/fasebj.22.2_supplement.433
2008-01-01
Abstract:We have previously shown that human alpha-defensins can block the release of IL-1beta from LPS-activated human monocytes. The objective of this study is to use defensins as tools to determine the molecular mechanism by which IL-1beta is processed and secreted from human monocytes. LPS-activated (20 ng/ml, 2 h), 35S-methionine-labeled (1 h) human monocytes were treated with human alpha-defensin HD-5 in the presence or absence of ATP, staphylococcal alpha-toxin (SAT), or nigericin (Nig) for 3 h. Media and cell–associated fractions were harvested separately. IL-1beta was recovered from each by immunoprecipitation and caspase-1 was examined by western blot analysis. It was found that HD-5 blocked the release of mature IL-1beta from cells treated with ATP or Nig, while HD-5 did not inhibit ATP- or Nig-induced caspase-1 activation and externalization. However, SAT-induced caspase-1 activation was blocked by HD-5 and cytosolic mature IL-1beta was not detected in cells treated with SAT and HD-5. To our knowledge, HD-5 is the first known endogenous inhibitor of IL-1beta release. This study suggest that although both IL-1beta and caspase-1 are detected in the extracellular milieu after ATP stimulation, mature IL-1beta and its converting enzyme caspase-1 are secreted via different pathways.
What problem does this paper attempt to address?